The impact of elexacaftor/tezacaftor/ivacaftor on fat-soluble vitamin levels in people with cystic fibrosis
Georgene E. Hergenroeder, Anna Faino, Gracia Bridges, Lauren Bartlett, Jonathan D. Cogen, Nicole Green, Sharon McNamara, David P. Nichols, Kathleen J. Ramos
Topics & Concepts
MedicineCystic fibrosisVitamin D and neurologyVitaminIvacaftorInternal medicinePhysiologyGastroenterologyCystic fibrosis transmembrane conductance regulatorCystic Fibrosis Research AdvancesAsthma and respiratory diseasesAntioxidant Activity and Oxidative Stress